(RTTNews) - Bausch Health Companies Inc. (BHC, BHC.TO), Bausch + Lomb, and Eyenovia, Inc., (EYEN) announced that an affiliate of Bausch Health has acquired an exclusive license in the United States ...

Atropine Sulfate Ophthalmic Solution USP, 1% has also been given 180 days of CGT exclusivity, the Weston, Fla.-based company said. [Read More: Upsher-Smith, Rafarm intro generic Vigamox] Indicated for ...

Use this medication in the affected eye(s) as directed by your doctor, usually 2 to 4 times daily. To apply eye drops, wash your hands first. To avoid contamination, do not touch the dropper tip or ...

A Prescription Drug User Fee Act target date of October 23, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

Bausch Health Companies Inc. BHC announced that it has acquired an exclusive license for an ophthalmic solution from clinical-stage ophthalmic biopharmaceutical company, Eyenovia EYEN, which is ...

Please provide your email address to receive an email when new articles are posted on . Santen and Sydnexis have finalized an exclusive licensing agreement for SYD-101 in Europe, Middle East and ...

NEW YORK--(BUSINESS WIRE)--Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, today announced that ...

A study from 7 institutions in Hong Kong reported that tapering of low-dose atropine before the drug was discontinued had more beneficial results for children with myopia. The inv ...

LONG BEACH, Calif. -- Low-dose atropine drops showed potential as a noninvasive alternative for managing vitreous floaters, a small retrospective study suggested. A majority of patients who completed ...

If you peek into classrooms around the world, a bunch of bespectacled kids peek back at you. In some countries such as China, as much as 80 percent of children are nearsighted. As those kids grow up, ...